Till now, most treatment guidelines have relied on hormone replacement therapy (HRT) for VMS, despite great demand and interest by both patient and clinician alike for non-hormonal, natural options for symptom management.3 As menopausal transition encompasses multiple years of care, clinical solutions limited to post-menopause are too limiting, thus effective natural solutions supporting peri-menopausal care fill an important gap in women’s health. With women reporting VMS during the menopausal transition years, over 40% of them report a desire- and preference- for use of natural solutions over HRT. Clinically supported natural solutions are an important part of managing VMS and associated increased risk of CVD.3,6

The Erasmus Medical Center Clinical Research Partnership – led by Principle Investigator Oscar Franco, MD, PhD who conducted groundbreaking research into improving women’s health particularly during the perimenopause and menopausal transition – this work has led to the development of recent updates to existing practice guidelines including those from NICE and EMAS.4-8

Download the PDF

Share this:

Resources from our research partners and collaborations

Sign up for the MHICN Newsletter

Your Weekly Nutrition Bulletin features the latest content on topics spanning our therapeutic platforms from MHICN research staff and clinical partners. Receive videos, clinical modules, research reviews and more by email each week. Sign up here or view previous weeks' newsletters.

Subscribe View Newsletter Archives

Continuing Education

MHICN has partnered with leaders in preventive medicine, integrative medicine, and medical education to provide cutting-edge education for providers of all backgrounds with an interest in functional and lifestyle medicine. We are excited to share these free educational modules featuring podcasts, videos, and print articles.

Learn More